These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2906068

  • 1. The natural history of tardive dyskinesia.
    Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH.
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J, Vogt Wehrli M, Stephan PL, Agarwalla P.
    Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM, Woerner M, Weinhold P, Wegner J, Kinon B.
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [Abstract] [Full Text] [Related]

  • 13. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J, Walsh E, van Horn E, Tattan T, Bale R, Thompson SG.
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [Abstract] [Full Text] [Related]

  • 14. Handedness and the risk of tardive dyskinesia.
    Morgenstern H, Glazer WM, Doucette JT.
    Biol Psychiatry; 1996 Jul 01; 40(1):35-42. PubMed ID: 8780853
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr 01; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Apr 01; 61 Suppl 4():15-20. PubMed ID: 10739326
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S, Sandmann U, Genz A.
    Pharmacopsychiatry; 2005 Jul 01; 38(4):171-7. PubMed ID: 16025420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.